Affimed N.V. AFMD
$ 2.8
-6.67%
Quarterly report 2022-Q2
added 08-11-2022
Country |
Germany |
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Adi Hoess |
Employees in the company |
137 |
Shares |
120 M |
Market Cap[1] |
$ 335 M |
EBITDA (LTM) |
$ -47.3 M |
P/E (LTM) |
-1.42 |
P/S (LTM) |
7.61 |
EPS (LTM) |
-0.62 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.